Artificial Intelligence – the “new new thing” in antitrust law – continues to permeate the health care industry in the United States. Competition law requires both awareness of the risk of anticompetitive conduct arising from a company’s reliance on AI, and cognizance that the eyes of federal and state antitrust enforcers, including the Department of Justice Antitrust Division and the Federal Trade Commission, are watching how companies incorporate AI into their business practices. Thi
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.133.124.23
Please verify email or join us to access premium content!